Future of Sales and Marketing beyond COVID - hybrid event in Vilnius: physical audience of 800 + 300 virtual. Digital marketing, location marketing. How to create MAGIC in new marketing campaigns. Future of Marketing Keynote Speaker

Chances of 2 people in 70 having same birthday? Managing Risk in Banking and Financial Services. Why the greatest risks are combinations of very unlikely events, which happen far more often than you expect. Keynote speaker on risk management

Compliance is Dead. How to build trust. Reputation of banks and financial services. Compliance Risks. Why 100% compliance with regulations, ESG requirements etc is often not enough to prevent reputational damage

Life's too short to do things you don't believe in! Why passionate belief in the true value of what you are selling or doing is the number one key to success. Secret of all leadership and marketing - keynote for 1100 people in Vilnius October 2021

Why you can't innovate on Zoom or Teams meetings - Innovation is almost impossible unless breathing same air, in same room

Why the key to rapid innovation is team diversity - survey global CEOs. Innovation keynote speaker

Future Manufacturing 5.0. Lessons from personal life for all manufacturers. Manufacturing Keynote

Future of Manufacturing: diagnostics; predictive analytics, little data and cybersecurity. Keynote

Manufacturing 5 0: The truth about robots, robotics and automation. Future of Manufacturing Keynote

Manufacturing 5.0 - why Manufacturing 4.0 not enough. Agility and Innovation: Manufacturing Keynote

Future of Manufacturing 5.0 - hyperconnected, sustainable factories and supply chains + human beings

80% of sales are won or lost in 3 seconds - Future of Marketing Keynote Speaker - Pardavimu formule

The Future of Ageing - Video / Article on Future Health

Futurist Keynote Speaker: Posts, Slides, Videos - Future Health Care and Pharma Keynote Speaker

How scientists will slow down or stop ageing in humans - Video

Comment by Dr Patrick Dixon on science of ageing, health care, life expectancy, medical advances, pensions, retirement, lifestyles and government policy.

Source: UC Berkely 1997

  • What if tables for length of life are wrong - and survival is about to jump by 5-10%? Answer: profound impact on insurance industry, pensions, and society as a whole. More - see future of medicine.
  • Inflammation may be a much more important factor in developing heart disease than formerly realised. Heart disease is multifactorial and complex, and no single theory seems to fit all the data. For example, many people with normal cholesterol get heart disease. Indeed half of all those who get heart attacks have cholesterol levels below 5.2 millimolews per litre (widely regarded as the safe limit). New links with general inflammation may explain why some researchers believe that infection with helicobacter pylori (the bug causing many stomach ulcers), cytomegalovirus, herpes simplex and helatitis A can all increase the risk of heart disease. New Scientist 11 January 2003
  • Expect huge investment in neuroscience by pharmaceutical companies over the next decade following progress in the 1990s in understanding brain physiology and disease mechanisms. Merck investment for example has jumped from 10% in 1995 to 30% in 2003. Areas to watch: prediction using gene secreening and new diagnostics, taking preventative action, more effective treatments. Expect new generations of antidepressants blocking uptake of serotonin and noradrenaline (dual uptake) with faster action and wider use.
  • Asthma cases worldwide have increased by 50% every decade for unknown reasons, but the rise may be stopping in Europe - especially Switzerland. Research conducted at Basle University - work presented at European Respiratory Society annual conference 2002.
  • 7,000 people every day die of malaria - a huge unsolved medical challenge. Only four drugs developed by the pharmaceutical industry in the last 20 years have been developed against malaria, yet malaria could become as rare as polio if an effective vaccine can be found. In 2002 there were just 480 polio cases - compared to 350,000 in 1988 - following global vaccination campaigns. The trouble is that malaria vaccine is not a great strategy for making money - if a company is successful they will be under pressure to give the patents away as a gift to the most vulnerable nations.

Future of biotechnology, genetics, health care, pharmaceutical industry

Dr Patrick Dixon lecture to biotech venture capital investors about future medicine and health care, gene therapy, biotechnology, and the pharmaceutical industry. Dr Dixon is a physician and trends analyst.

Related news items:
Newer news items:
Older news items:

Thanks for promoting with Facebook LIKE or Tweet. Really interested to read your views. Post below.

Join the Debate! What are your own views?



Search for your future

Our cookie policy

We use cookies for statistical purposes. To comply with the e-Privacy Directive we need to ask your consent to place these cookies on your computer.

Your use of this site indicates acceptance of these terms. I accept